These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1474543)

  • 61. Comparison of the effects of nabumetone with indomethacin on rat gastric mucosal 6-keto-PGF1 alpha production and on bile salt-induced changes in gastric mucosal function.
    Melarange R; Rashbrook LC
    J Pharm Pharmacol; 1987 Sep; 39(9):717-20. PubMed ID: 2445949
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.
    Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
    Agents Actions; 1992; Spec No():C82-3. PubMed ID: 1442340
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of the antiinflammatory prodrug, nabumetone and its principal active metabolite on rat gastric mucosal, aortic and platelet eicosanoid synthesis, in vitro and ex vivo.
    Jeremy JY; Thompson CS; Mikhailidis DP; Dandona P
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):195-9. PubMed ID: 2281122
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of the prodrug nabumetone, and its active metabolite, 6-MNA, on human and rat gastric mucosal prostanoids and platelet function.
    Jeremy JY; Mikhailidis DP; Barradas MA; Kirk RM; Dandona P
    Drugs; 1990; 40 Suppl 5():53-6. PubMed ID: 2081494
    [No Abstract]   [Full Text] [Related]  

  • 65. The effect of nabumetone and its principal active metabolite on in vitro human gastric mucosal prostanoid synthesis and platelet function.
    Jeremy JY; Mikhailidis DP; Barradas MA; Kirk RM; Dandona P
    Br J Rheumatol; 1990 Apr; 29(2):116-9. PubMed ID: 2108782
    [TBL] [Abstract][Full Text] [Related]  

  • 66. How do non-steroidal anti-inflammatory drugs affect gastric mucosal defenses?
    Fromm D
    Clin Invest Med; 1987 May; 10(3):251-8. PubMed ID: 3304754
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Etiological mechanism and drug-induced gastric mucosal lesions].
    Kawano S; Tsuji S; Masuda E; Kamada T
    Nihon Naika Gakkai Zasshi; 1995 Feb; 84(2):230-4. PubMed ID: 7722388
    [No Abstract]   [Full Text] [Related]  

  • 68. [Reactive oxygen species and free radical reactions are involved in the pathogenesis of non-steroidal anti-inflammatory drugs-induced gastric mucosal injury].
    Naito Y; Yoshikawa T
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():211-6. PubMed ID: 11979780
    [No Abstract]   [Full Text] [Related]  

  • 69. NSAIDS and the microcirculation of the stomach.
    Kawano S; Tsuji S; Sato N; Kamada T
    Gastroenterol Clin North Am; 1996 Jun; 25(2):299-315. PubMed ID: 9229574
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Nabumetone, a new nonsteroidal antiinflammatory agent: clinical prospects].
    Nasonov EL; Nasonova SV
    Klin Med (Mosk); 1996; 74(8):13-6. PubMed ID: 9036198
    [No Abstract]   [Full Text] [Related]  

  • 71. Nonsteroidal antiinflammatory drug use in patients receiving warfarin: emphasis on nabumetone.
    Hilleman DE; Mohiuddin SM; Lucas BD
    Am J Med; 1993 Aug; 95(2A):30S-34S. PubMed ID: 8357000
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Why are non-steroidal anti-inflammatory drugs so variable in their efficacy? A description of ion trapping.
    Ellis GA; Blake DR
    Ann Rheum Dis; 1993 Mar; 52(3):241-3. PubMed ID: 8484682
    [No Abstract]   [Full Text] [Related]  

  • 73. The effect of nabumetone and indomethacin on gastric mucosal function.
    Shorrock CJ; Rees WD
    J Rheumatol Suppl; 1992 Nov; 36():85-8. PubMed ID: 1474543
    [No Abstract]   [Full Text] [Related]  

  • 74. The unique pharmacologic profile of nabumetone.
    Blower PR
    J Rheumatol Suppl; 1992 Nov; 36():13-9. PubMed ID: 1474529
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.